<p>Christine Ring, Chief Legal Officer of Nurix Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817199-25-000010), on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

NRIX

<p>Christine Ring, Chief Legal Officer of Nurix Therapeutics Inc., reported the disposal of common shares of the company. The information was published via EDGAR by Nurix Therapeutics on December 18, 2025. This brief was created by Public Technologies using AI and is for informational purposes only.</p>

Nurix Therapeutics Chief Legal Officer Christine Ring Reports Disposal of Common Shares